Clinical trial
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (CATCH-AF in Patients With Impaired LV Function): An Early Ablation Strategy Study Impact on Health Care Utilization
NCT02686749 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (CATCH-AF in Patients With Impaired LV Function): An Early Ablation Strategy Study Impact on Health Care Utilization
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2016
- Completion date
- October 1, 2018
- Enrollment
- 4 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, congestive heart failure, left ventricular failure